An immunological link between Candida albicans colonization and Crohn’s disease

References

• Abraham C, Cho J. (2009). Inflammatory bowel disease. N Engl J Med 361:2066–78
   PubMed Web of Science ®Google Scholar
• Barrett JC, Hansoul S, Nicolae DL, et al. (2008). Genome-wide association defines more than 30 distinct susceptibility loci for Crohn’s disease. Nat Genet 40:955–62
   PubMed Web of Science ®Google Scholar
• Bernhardt H, Knoke M. (1997). Mycological aspects of gastrointestinal microflora. Scand J Gastroenterol Suppl 222:102–6
   PubMedGoogle Scholar
• Brand S. (2009). Crohn's disease: Th1, Th17 or both? The change of a paradigm: new immunological and genetic insights implicate Th17 cells in the pathogenesis of Crohn's disease. Gut 58:1152–67
   PubMed Web of Science ®Google Scholar
• Brown GD, Gordon S. (2001). Immune recognition. A new receptor for beta-glucans. Nature 413:36–7
   PubMed Web of Science ®Google Scholar
• Brown GD, Herre J, Williams DL, et al. (2003). Dectin-1 mediates the biological effects of beta-glucans. J Exp Med 197:1119–24
   PubMed Web of Science ®Google Scholar
• Cheng SC, van de Veerdonk FL, Lenardon M, et al. (2011). The dectin-1/inflammasome pathway is responsible for the induction of protective T-helper 17 responses that discriminate between yeasts and hyphae of Candida albicans. J Leukoc Biol 90:357–66
   PubMed Web of Science ®Google Scholar
• Cho J. (2008). The genetics and immunopathogenesis of inflammatory bowel disease. Nat Rev Immunol 8:458–66
   PubMed Web of Science ®Google Scholar
• Chouraki V, Savoye G, Dauchet L, et al. (2011). The changing pattern of Crohn's disease incidence in northern France: a continuing increase in the 10- to 19-year-old age bracket (1988–2007). Aliment Pharmacol Ther 33:1133–42
   PubMed Web of Science ®Google Scholar
• Colombel JF, Sendid B, Jouault T, Poulain D. (2013). Secukinumab failure in Crohn's disease: the yeast connection? Gut 62:800–1
   PubMed Web of Science ®Google Scholar
• Darfeuille-Michaud A, Boudeau J, Bulois P, et al. (2004). High prevalence of adherent-invasive Escherichia coli associated with ileal mucosa in Crohn's disease. Gastroenterology 127:412–21
   PubMed Web of Science ®Google Scholar
• Deretic V. (2012). Autophagy as an innate immunity paradigm: expanding the scope and repertoire of pattern recognition receptors. Curr Opin Immunol 24:21–31
   PubMed Web of Science ®Google Scholar
• Dotan I, Fishman S, Dgani Y, et al. (2006). Antibodies against laminaribioside and chitobioside are novel serologic markers in Crohn's disease. Gastroenterology 131:366–78
   PubMed Web of Science ®Google Scholar
• Eyerich K, Foerster S, Rombold S, et al. (2008). Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th17-associated cytokines IL-17 and IL-22. J Invest Dermatol 128:2640–5
   PubMed Web of Science ®Google Scholar
• Ferrante M, Henckaerts L, Joossens M, et al. (2007). New serological markers in inflammatory bowel disease are associated with complicated disease behaviour. Gut 56:1394–403
   PubMed Web of Science ®Google Scholar
• Franke A, McGovern DPB, Barrett JC, et al. (2010). Genome-wide meta-analysis increases to 71 the number of confirmed Crohn's disease susceptibility loci. Nat Genet 42:1118–25
   PubMed Web of Science ®Google Scholar
• Gantner BN, Simmons RM, Underhill DM. (2005). Dectin-1 mediates macrophage recognition of Candida albicans yeast but not filaments. EMBO J 24:1277–86
   PubMed Web of Science ®Google Scholar
• Gladiator A, Wangler N, Trautwein-Weidner K, Leibundgut-Landmann S. (2012). Cutting Edge: IL-17-secreting innate lymphoid cells are essential for host defense against fungal infection. J Immunol 190:521–5
   Google Scholar
• Gow NA, van de Veerdonk FL, Brown AJ, Netea MG. (2012). Candida albicans morphogenesis and host defence: discriminating invasion from colonization. Nat Rev Microbiol 10:112–22
   PubMed Web of Science ®Google Scholar
• Hueber W, Sands BE, Lewitzky S, et al. (2012). Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind placebo-controlled trial. Gut 61:1693–700
   PubMed Web of Science ®Google Scholar
• Hugot J, Chamaillard M, Zouali H, et al. (2001). Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599–603
   PubMed Web of Science ®Google Scholar
• Iliev ID, Funari VA, Taylor KD, et al. (2012). Interactions between commensal fungi and the C-type lectin receptor Dectin-1 influence colitis. Science 336:1314–7
   PubMed Web of Science ®Google Scholar
• Jawhara S, Thuru X, Standaert-Vitse A, et al. (2008). Colonization of mice by Candida albicans is promoted by chemically induced colitis and augments inflammatory responses through galectin-3. J Infect Dis 197:972–80
   PubMed Web of Science ®Google Scholar
• Jouault T, El Abed-El Behi M, Martinez-Esparza M, et al. (2006). Specific recognition of Candida albicans by macrophages requires galectin-3 to discriminate Saccharomyces cerevisiae and needs association with TLR2 for signaling. J Immunol 177:4679–87
   PubMed Web of Science ®Google Scholar
• Jouault T, Sarazin A, Martinez-Esparza M, et al. (2009). Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cell Microbiol 11:1007–15
   PubMed Web of Science ®Google Scholar
• Jyonouchi H, Geng L, Cushing-Ruby A, Monteiro I. (2010). Aberrant responses to TLR agonists in pediatric IBD patients; the possible association with increased production of Th1/Th17 cytokines in response to Candida, a luminal antigen. Pediatr Allergy Immunol 21:747–55
   PubMed Web of Science ®Google Scholar
• Li X, Conklin L, Alex P. (2008). New serological biomarkers of inflammatory bowel disease. World J Gastroenterol 14:5115–24
   PubMed Web of Science ®Google Scholar
• Macfarlan G, Blackett K, Nakayama T, et al. (2009). The gut microbiota in inflammatory bowel disease. Curr Pharm Des 15:1528–36
   PubMedGoogle Scholar
• McGovern D, Powrie F. (2007). The IL23 axis plays a key role in the pathogenesis of IBD. Gut 56:1333–6
   PubMed Web of Science ®Google Scholar
• McKenzie H, Main J, Pennington C, Parratt D. (1990). Antibody to selected strains of Saccharomyces cerevisiae (baker's and brewer's yeast) and Candida albicans in Crohn's disease. Gut 31:536–8
   PubMed Web of Science ®Google Scholar
• Milner JD, Brenchley JM, Laurence A, et al. (2008). Impaired T(H)17 cell differentiation in subjects with autosomal dominant hyper-IgE syndrome. Nature 452:773–6
   PubMed Web of Science ®Google Scholar
• Nerich V, Monnet E, Etienne A, et al. (2006). Geographical variations of inflammatory bowel disease in France: a study based on national health insurance data. Inflamm Bowel Dis 12:218–26
   PubMed Web of Science ®Google Scholar
• Nicola AM, Albuquerque P, Martinez LR, et al. (2012). Macrophage autophagy in immunity to Cryptococcus neoformans and Candida albicans. Infect Immun 80:3065–76
   PubMed Web of Science ®Google Scholar
• Ott SJ, Kuhbacher T, Musfeldt M, et al. (2008). Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scand J Gastroenterol 43:831–41
   PubMed Web of Science ®Google Scholar
• Perlroth J, Choi B, Spellberg B. (2007). Nosocomial fungal infections: epidemiology, diagnosis, and treatment. Med Mycol 45:321–46
   PubMed Web of Science ®Google Scholar
• Poulain D, Sendid B, Standaert-Vitse A, et al. (2009). Yeasts: neglected pathogens. Digest Dis 27:104–10
   PubMed Web of Science ®Google Scholar
• Quinton JF, Sendid B, Reumaux D, et al. (1998). Anti-Saccharomyces cerevisiae mannan antibodies combined with antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease: prevalence and diagnostic role. Gut 42:788–91
   PubMed Web of Science ®Google Scholar
• Rehaume LM, Jouault T, Chamaillard M. (2010). Lessons from the inflammasome: a molecular sentry linking Candida and Crohn's disease. Trends Immunol 31:171–5
   PubMedGoogle Scholar
• Rieder F, Lopez R, Franke A, et al. (2011). Characterization of changes in serum anti-glycan antibodies in Crohn's disease – a longitudinal analysis. PLoS ONE 6:e18172
   PubMed Web of Science ®Google Scholar
• Roberts RL, Topless RKG, Phipps-Green AJ, et al. (2010). Evidence of interaction of CARD8 rs2043211 with NALP3 rs35829419 in Crohn's disease. Genes Immun 11:351–6
   PubMed Web of Science ®Google Scholar
• Saitoh T, Fujita N, Jang MH, et al. (2008). Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456:264–8
   PubMed Web of Science ®Google Scholar
• Sartor R. (2008). Microbial influences in inflammatory bowel diseases. Gastroenterology 134:577–94
   PubMed Web of Science ®Google Scholar
• Seksik P, Rigottier-Gois L, Gramet G, et al. (2003). Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon. Gut 52:237–42
   PubMed Web of Science ®Google Scholar
• Sendid B, Colombel JF, Jacquinot PM, et al. (1996). Specific antibody response to oligomannosidic epitopes in Crohn's disease. Clin Diagn Lab Immunol 3:219–26
   PubMedGoogle Scholar
• Sendid B, Dotan N, Nseir S, et al. (2008). Antibodies against glucan, chitin, and Saccharomyces cerevisiae mannan as new biomarkers of Candida albicans infection that complement tests based on C. albicans mannan. Clin Vaccine Immunol 15:1868–77
   PubMedGoogle Scholar
• Sendid B, Jouault T, Vitse A, et al. (2009). Anti-glycan antibodies establish an unexpected link between C. albicans and Crohn disease. Med Sci 25:473–81
   Google Scholar
• Sendid B, Quinton JF, Charrier G, et al. (1998). Anti-Saccharomyces cerevisiae mannan antibodies in familial Crohn's disease. Am J Gastroenterol 93:1306–10
   PubMed Web of Science ®Google Scholar
• Shi CS, Shenderov K, Huang NN, et al. (2012). Activation of autophagy by inflammatory signals limits IL-1beta production by targeting ubiquitinated inflammasomes for destruction. Nat Immunol 13:255–63
   PubMed Web of Science ®Google Scholar
• Sokol H, Seksik P, Furet JP, et al. (2009). Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 15:1183–9
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Jouault T, Vandewalle P, et al. (2006). Candida albicans is an immunogen for anti-Saccharomyces cerevisiae antibody markers of Crohn's disease. Gastroenterology 130:1764–75
   PubMed Web of Science ®Google Scholar
• Standaert-Vitse A, Sendid B, Joossens M, et al. (2009). Candida albicans colonization and ASCA in familial Crohn's disease. Am J Gastroenterol 104:1745–53
   PubMed Web of Science ®Google Scholar
• Travassos LH, Carneiro LA, Girardin S, Philpott DJ. (2010). Nod proteins link bacterial sensing and autophagy. Autophagy 6:409–11
   PubMed Web of Science ®Google Scholar
• Van Limbergen J, Wilson D, Satsangi J. (2009). The genetics of Crohn's disease. Annu Rev Genomics Hum Genet 10:89–116
   PubMed Web of Science ®Google Scholar
• Vasseur F, Sendid B, Jouault T, et al. (2012). Variants of NOD1 and NOD2 genes display opposite associations with familial risk of Crohn's disease and anti-saccharomyces cerevisiae antibody levels. Inflamm Bowel Dis 18:430–8
   PubMedGoogle Scholar
• Wildenberg ME, Vos AC, Wolfkamp SC, et al. (2012). Autophagy attenuates the adaptive immune response by destabilizing the immunologic synapse. Gastroenterology 142:1493–503
   PubMed Web of Science ®Google Scholar
• Zelante T, De Luca A, D'Angelo C, et al. (2009). IL-17/Th17 in anti-fungal immunity: what's new? Eur J Immunol 39:645–8
   PubMed Web of Science ®Google Scholar